Holen Sie sich die Stockscreener-App
0.407
6.22%
-0.027
Handel nachbörslich:
.43
0.023
+5.65%
Finanzdaten der Ensysce Biosciences Inc-Aktie (ENSC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
62.64%
0.4931
|
1.3198 | 1.3037 | 3.4189 | 0.1818 |
Operating Expenses
|
28.81%
4.2342
|
3.2873 | 4.8801 | 2.7741 | 2.1372 |
| Benefits Costs and Expenses |
29.30%
4.2222
|
3.2653 | 4.8681 | 2.7571 | 2.1496 |
| Costs And Expenses |
29.30%
4.2222
|
3.2653 | 4.8681 | 2.7571 | 2.1496 |
| Operating Income/Loss |
90.14%
-3.7411
|
-1.9675 | -3.5765 | 0.6447 | -1.9554 |
| Nonoperating Income/Loss |
45.45%
0.012
|
0.0219 | 0.0121 | 0.017 | -0.0124 |
| Income/Loss From Continuing Operations Before Tax |
91.67%
-3.7291
|
-1.9456 | -3.5644 | 0.6618 | -1.9678 |
| Income/Loss From Continuing Operations After Tax |
91.67%
-3.7291
|
-1.9456 | -3.5644 | 0.6618 | -1.9678 |
|
Net Income/Loss
|
91.67%
-3.7291
|
-1.9456 | -3.5644 | 0.6618 | -1.9678 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | -0.00029 | - | - |
| Basic Average Shares |
105.98%
2.8861
|
1.4011 | -7.0849 | 9.8904 | 8.8173 |
| Diluted Average Shares |
105.98%
2.8861
|
1.4011 | -7.0849 | 9.8904 | 8.8173 |
| Basic Earnings Per Share |
7.19%
-1.29
|
-1.39 | -10.88 | 0.07 | -0.22 |
| Diluted Earnings Per Share |
7.19%
-1.29
|
-1.39 | -10.88 | 0.07 | -0.22 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):